Health

Molina called its $6 billion Florida launch 'nearly flawless'; the state is investigating unpaid claims

Molina Healthcare told investors its $6 billion Florida children's Medicaid contract started cleanly. A day later, the state's health-care agency confirmed it is investigating unpaid claims from the autism-therapy providers serving those children.

Vincent JiangVincent Jiang · 3 min read
Share
A behavioral therapist works with a young boy during an applied behavior analysis session, the therapy Florida pays for through the Children's Medical Services Plan
1 / 5Slide 1 of 5
An ABA session: Florida's Children's Medical Services Plan pays for the therapy, and the providers delivering it say Molina has left them unpaid since October 1.

Arlene Perez, a registered behavior technician, has worked for five years with a 12-year-old boy on the autism spectrum 1. Since Florida moved his plan to Molina Healthcare−0.83% — Molina Healthcare, down 0.83 percent today on October 1, she says she has not received a paycheck 1. Her agency reports most of its claims unprocessed since the switch, and Perez joined providers rallying outside Molina's Doral office. "I will until I can't. There's gonna be a moment where I have to look for something else to pay my bills," she told CBS Miami 1.

A $6 billion contract is the recovery plan

The plan is Florida's Children's Medical Services Plan, Medicaid and CHIP coverage for children with special health care needs. Molina became its sole statewide operator on October 1, replacing Centene's−4.23% — Centene, down 4.23 percent today Sunshine Health, taking on 115,000 members and about $6 billion a year in run-rate revenue 1. CEO Joseph Zubretsky gave investors the same figures on October 22, and the contract anchors the $4 per share of embedded earnings Molina expects to harvest in 2027 25.

Flawless on the call, unpaid claims in Doral

Zubretsky called the first 22 days of the program "nearly flawless" 2. The next day, CBS Miami reported the payment fight: medical attorney Henry Marines, who says he communicates with almost 700 providers, said "they all say the same thing 1. They haven't been paid" (a count this desk could not verify) 1. Florida's Agency for Health Care Administration says it is "actively investigating payment concerns raised by ABA providers." Molina has not responded, and the published call transcripts contain no discussion of the complaints 1.

The margin math has no room for a broken pay run

Quarterly net income fell to $38 million from $79 million a year earlier, and nine-month net income to $112 million from $632 million, which this site covered when the October 21 results landed 4. Medicaid medical costs absorbed 93.0% of premiums in the quarter, up from 92.0% 4.

Quarterly profit has halved year over year, and nine-month profit is down 82%

$0M$200M$400M$600M$800MQ3 2025Q3 20269M 20259M 2026$112M$38M
Data
Net income
Q3 2025$79M
Q3 2026$38M
9M 2025$632M
9M 2026$112M
Net income for the third quarter and the first nine months, year over year. Sources: Molina figures via LineVest (4); the site's October 21 results coverage.4

CFO Mark Keim projected the Florida contract would run medical costs at about 99% of premium in the fourth quarter, a 5% pre-tax loss on $1.5 billion of revenue, two points of it one-time new-business reserves 2. The 2026 outlook books a $1.50-per-share launch loss, and the recovery needs Florida at breakeven or better in 2027 25.

Molina's Medicaid cost ratio keeps climbing, and Florida is projected at 99%

  • Medicaid medical costs as % of premiums
  • Estimate
0%50%100%Q3 2024Q3 2025Q3 2026Q4 2026 (CMS, projected)93%
Data
Medicaid medical costs as % of premiums
Q3 202490.5%
Q3 202592%
Q3 202693%
Q4 2026 (CMS, projected) (estimate)99%
Medicaid medical costs as a share of Medicaid premiums. Q4 2026 is management's projection for the newly launched Florida Children's Medical Services contract, drawn dashed. Sources: Molina 10-Q figures via LineVest (4); Q3 2026 earnings call, CFO Mark Keim (2).2,4

Molina's defense, and where it thins

Keim told investors days in claims payable stood at 44, consistent with the prior quarter 2, and a one-month backlog in a handover of 115,000 complex cases can be transition noise rather than a broken machine. The state's own rules cut the other way: an April alert from AHCA promised providers prompt payment and pre-switch rates honored into late May 2027 1.

What settles it before the fourth-quarter print

Watch the AHCA investigation and the meeting Marines plans with Molina's senior executives 1. The fourth-quarter report, due in February, is the first reading of the 99% projection and of whether providers stay 1. Florida pays Molina for every enrolled child from day one; the children's therapists are still waiting.

Get Health by email, free

AI in medicine, pharma and biotech. In our daily email, every weekday.

Loading MOH

Reader comments

0 comments

    More in Health

    All in this topic →

    Health

    Doximity reports November 5: growth slowed from 23.2% to 7.3% while a securities suit names its CEO

    Doximity reports fiscal Q2 on November 5 while a securities class action over its Newsfeed claims heads toward a November 16 deadline, and its newest product, the AI safety layer DoseCheck, shipped free three days before the print with no published price.

    Health

    Employers are cutting GLP-1 coverage; Novo Nordisk sells Wegovy outside insurance for $149 to $199 a month

    Employer plans are cutting GLP-1 coverage at the fastest health-cost pace since 2003, and Novo's answer is to route the same patients outside insurance through Andel, a checkout rail it shares with rival Eli Lilly. Novo reports Q3 on November 4 with consensus at $0.73 per ADR on $11.08 billion.

    Health

    Tempus posts record revenue and a first adjusted profit, with a $1.5 billion stock deal still on the table

    The record $411.5 million quarter delivered Tempus's first adjusted profit, but the GAAP loss remains and the $1.5 billion Personalis acquisition is set to be paid for in Tempus shares, with a shareholder vote on November 30.

    Health

    Epic won FDA clearance for its deterioration score with rival AgileMD's algorithm as the benchmark

    The FDA found Epic's rebuilt patient-deterioration score substantially equivalent to AgileMD's eCARTv5, making the challenger's algorithm the benchmark the EHR giant had to match. With a mortality study behind it, Epic's bundled score resets the math for hospital AI vendors.

    Health

    Bristol Myers locked Tempus data through 2031 and led Pathos' $237 million round; Tempus reports November 2

    Bristol Myers Squibb extended its Tempus oncology data license through 2031 and, the same week, led rival Pathos AI's $237 million Series E. Tempus reports Q3 on Monday, November 2, and the print decides which layer of its own stack the market pays for.

    Health

    Lilly raises guidance to $92 billion and hits a record close, while Novo Nordisk bets November on CagriSema

    Lilly just priced its clinical lead at 31 times earnings while Novo Nordisk trades at 12x, and Novo's November congress calendar is the last scheduled chance to argue back before retatrutide's FDA filing closes the record.

    Get the newsletter

    The day's AI and market news, in your inbox every weekday.